-+ 0.00%
-+ 0.00%
-+ 0.00%
Assessing Integer Holdings (ITGR) Valuation After Mixed Recent Performance And Modest Undervaluation Estimate
Share
Listen to the news

Recent share performance and business overview

Integer Holdings (ITGR) has drawn investor attention after recent share price moves, with the stock last closing at US$89.28 and showing mixed returns over the past month and the past 3 months.

See our latest analysis for Integer Holdings.

Zooming out, the stock has a 16.28% year to date share price return, while the 1 year total shareholder return is down 24.54%. This suggests recent momentum contrasts with weaker results over a longer horizon as investors reassess growth prospects and risks.

If you want to see what other areas of the market are gaining attention, this could be a good time to look at 34 healthcare AI stocks

With a 16.28% year to date gain but a 24.54% decline over 1 year, plus an indicated intrinsic discount to current pricing, should you view Integer Holdings as undervalued, or is the market already accounting for possible future growth?

Most Popular Narrative: 6% Undervalued

At a last close of $89.28 versus a narrative fair value of $95.00, Integer Holdings is framed as modestly undervalued, with that gap built on detailed earnings and margin assumptions.

The company's strong pipeline of new product launches concentrated in faster-growing categories, such as advanced electrophysiology tools and neuromodulation devices, positions it to capitalize on industry-wide technological advancements and the shift toward minimally invasive procedures, supporting future revenue and market share expansion.

Read the complete narrative.

Want to see what sits behind that growth story and valuation gap? The narrative leans on specific revenue run rates, margin steps, and a future earnings multiple that many investors usually associate with faster growing medical stocks.

Result: Fair Value of $95 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that fair value gap can narrow quickly if customer concentration or the underperforming neuromodulation and portable medical programs reduce revenue and margin assumptions more than expected.

Find out about the key risks to this Integer Holdings narrative.

Next Steps

Mixed signals on value and future prospects can feel unresolved, so act now by reviewing the data, weighing both concerns and potential upsides, and checking the 4 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Integer Holdings has raised fresh questions about your portfolio, this is a strong moment to widen your search and spot other opportunities that might suit your approach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending